abrdn Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
abrdn Investment Management's ABBV Position: Q2 2017 in Review
abrdn Investment Management reduced its AbbVie (ABBV) stake by 1.7% in Q2 2017, selling an estimated $330K and leaving 281,085 shares worth $20.4M. The position accounts for 0.07% of the portfolio, ranked #148.
abrdn Investment Management first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. The position peaked at $335M in Q4 2014. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.
- abrdn Investment Management held 281,085 shares of AbbVie worth $20.4M as of Q2 2017.
- abrdn Investment Management sold 4,910 AbbVie shares in Q2 2017, an estimated $330K.
- AbbVie made up 0.07% of abrdn Investment Management's portfolio in Q2 2017, its #148 holding.
- abrdn Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
- abrdn Investment Management's AbbVie position peaked at $335M in Q4 2014.
- 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.